The city of Mcallen, Texas, currently has 2 active clinical trials seeking participants for Pulmonary Fibrosis research studies.
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Recruiting
Study RIN-PF-305 is designed to evaluate the safety and efficacy of inhaled treprostinil in subjects with progressive pulmonary fibrosis (PPF) over a 52-week period.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/17/2024
Locations: A & A Research Consultants, LLC, McAllen, Texas
Conditions: Progressive Pulmonary Fibrosis, Interstitial Lung Disease
Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
Recruiting
Study RIN-PF-301 is designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FVC) from baseline to Week 52.
Gender:
All
Ages:
40 years and above
Trial Updated:
03/01/2024
Locations: A & A Research Consultants, LLC, McAllen, Texas
Conditions: Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease